首页> 外文OA文献 >Evaluation of survival and ischaemic and thromboembolic event rates in patients with non‐valvar atrial fibrillation in the general population when treated and untreated with warfarin

【2h】

Evaluation of survival and ischaemic and thromboembolic event rates in patients with non‐valvar atrial fibrillation in the general population when treated and untreated with warfarin

机译：在华法林治疗和未治疗的情况下，评估一般人群中非瓣膜性房颤患者的生存率，缺血性和血栓栓塞事件发生率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Currie, C J; Jones, M; Goodfellow, J; McEwan, P; Morgan, C L; Emmas, C; Peters, J R;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin [J] . C J Currie, M Jones, J Goodfellow, Heart . 2006,第2期

机译：在华法林治疗和未治疗的情况下，评估普通人群中非瓣膜性房颤患者的生存率，缺血性和血栓栓塞事件发生率
2. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial [J] . Garcia David A., Fisher Deborah A., Mulder Hillary, Autonomic neuroscience: basic & clinical . 2019,第1期

机译：用Apixaban或Warfarin治疗心房颤动患者的胃肠道出血：来自细胞腺癌的脑卒中和地心房颤动（亚里士多德）试验中的其他血栓栓塞事件的见解
3. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population [J] . M Jones, P McEwan, C Ll Morgan, Heart . 2005,第4期

机译：非瓣膜性心房颤动患者的治疗模式，抗凝控制水平和华法林治疗结果的评估：一项在英国大量人群中的记录关联研究
4. Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients [C] . Shijing Guo, Xiang Li, Xin Du, MEDINFO . 2017

机译：基于组的术语轨迹分析，用于高级患者的华法林治疗
5. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
6. Evaluation of survival and ischaemic and thromboembolic event rates in patients with non‐valvar atrial fibrillation in the general population when treated and untreated with warfarin [O] . C J Currie, M Jones, J Goodfellow, 2006

机译：在华法林治疗和未治疗的情况下评估一般人群中非瓣膜性房颤患者的生存率缺血性和血栓栓塞事件发生率
7. CV4 EVALUATION OF SURVIVAL AND ISCHAEMIC AND THROMBOEMBOLIC EVENT RATES IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN THE GENERAL POPULATION WHEN TREATED AND UNTREATED WITH WARFARIN [O] . Jones M, Currie CJ, McEwan P 2004

机译：用华法林治疗和未治疗的一般人群中非瓣膜性心房颤动患者的生存率，缺血性和血栓性和栓塞代谢率的评估

Evaluation of survival and ischaemic and thromboembolic event rates in patients with non‐valvar atrial fibrillation in the general population when treated and untreated with warfarin

著录项

相似文献

相关主题

期刊订阅